Pathology Portal

Assessment- Clonal Haematopoiesis and Clonal Cytopenias of Uncertain Significance (CCUS)

Certificate available: complete this course to be awarded a certificate

Not yet rated

Resource details

The presentation focuses on clonal haematopoiesis (CH) and clonal cytopenias of uncertain significance (CCUS), highlighting their role in the development of haematological malignancies and the importance of early identification and management. The presentation begins by outlining the classification of myeloid neoplasms, referencing the World Health Organization’s (WHO) 5th edition (2022) and 4th edition (2017) classifications. These classifications encompass acute myeloid leukemia (AML), myelodysplastic syndromes (MDS), chronic myelomonocytic leukemia (CMML), and classical myeloproliferative neoplasms (MPNs) such as essential thrombocythemia (ET) and polycythemia vera (PV).

Contributed by: Pathology Portal
Authored by: Dr Emily Mitchell, Cambridge University Hospitals NHS Foundation Trust, Consultant in Haemato-Oncology Diagnostic Service,(HODS)
Dr Pallota Perinde, Pathology Portal
Licence: Creative commons: Attribution-NonCommercial 4.0 International More information on licences
First contributed: 03 December 2024
Audience access level: General user

Ratings

0 ratings

Not yet rated
5 star
0%
4 star
0%
3 star
0%
2 star
0%
1 star
0%
Report an issue with this resource

You may report a resource, for example, if there is an issue with copyright infringement, breach of personal data, factual inaccuracies, typing errors or safety concerns. The type of issue will determine whether the resource is immediately removed from the platform or if the contributor is asked to make amendments. You can report a resource from the resource information page or by contacting the Learning Hub support team.

You can contact the Learning Hub support team by completing the support form or if you have a general enquiry you can email enquiries@learninghub.nhs.uk.